Follow the RenovoRx, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, RenovoRx, Inc. has published 23 insider filings. Market capitalisation: €39.9m. The latest transaction was disclosed on 24 March 2026 (Acquisition). Among the most active insiders: Bagai Shaun. Every trade is free.
23
Insider Decl.
0
Thresholds
€117,895
19 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate RenovoRx, Inc. Strong Buy (bullish), based on 4 analysts. Average price target: US$7.03.
55Σ signal
Buys €117,895· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,990 of 25,791 companies
26.4
score / 100
Value
8
Quality
45
FCF yld-26%
Earn yld-27%
EV/EBITDA·
ROE-100%
Gross mgn71%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.